Top compounds associated with response to CREB5


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.07
mRNA Sorafenib GDSC1000 pan-cancer AAC -0.1 0.07
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC -0.12 0.07
mRNA myriocin CTRPv2 pan-cancer AAC 0.15 0.07
mRNA cimetidine CTRPv2 pan-cancer AAC 0.13 0.07
mRNA ISOX CTRPv2 pan-cancer AAC 0.064 0.07
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.07
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.08
mRNA YK 4-279 GDSC1000 pan-cancer AAC 0.07 0.08
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.071 0.08
Download CSV